Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 2 results out of 2
Data Insights
Anhydrous enol oxaloacetate by MetVital for Fatigue: Likelihood of Approval
Anhydrous enol oxaloacetate is under clinical development by MetVital and currently in Phase II for Fatigue. According to GlobalData, Phase...
Data Insights
Anhydrous enol oxaloacetate by MetVital for Amyotrophic Lateral Sclerosis: Likelihood of Approval
Anhydrous enol oxaloacetate is under clinical development by MetVital and currently in Phase I for Amyotrophic Lateral Sclerosis. According to...